IRIS

Sfoglia per Rivista  DIABETOLOGIA

Opzioni
Vai a: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Mostrati risultati da 47 a 66 di 128
Titolo Data di pubblicazione Autore(i) File
Fasting and meal-stimulated residual beta cell function is positively associated with serum concentrations of proinflammatory cytokines and negatively associated with anti-inflammatory and regulatory cytokines in patients with longer term type 1 diabetes 1-gen-2013 Pham, Mn; Kolb, H; Battelino, T; Ludvigsson, J; Pozzilli, P; Zivehe, F; Roden, M; Mandrup-Poulsen, T; Schloot, Nc
Fasting and stimulated C-peptide at aseline in DEFEND-1, a phase 3 study of otelixizumab in new onset type 1 diabetes 1-gen-2010 Pozzilli, P; Ghirlanda, G; Brennan, Am; Belanger, B; Mckee, Cm
Fracture risk in diabetic elderly men: the MrOS study 1-gen-2014 Napoli, N; Strotmeyer Elsa, S.; Ensrud Kristine, E.; Sellmeyer Deborah, E.; Bauer Douglas, C.; Hoffman Andrew, R.; Dam Thuy-Tien, L.; Barrett-Connor, Elizabeth; Palermo, Lisa; Orwoll Eric, S.; Cummings Steven, R.; Black Dennis, M.; Schwartz Ann, V.
Free Fatty acids (FFA) and endothelial dysfunction; role of increased oxidative stress and inflammation - to: Gale EAM (2002) A missing link in the hygiene hypothesis? Diabetologia 45 : 588-592 - Comment 1-gen-2003 Beyan, H; Valorani, Mg; Pozzilli, P
Free time activities and blood glucose control in patients with type 1 diabetes 1-gen-2008 Bizzarri, C; Benevento, D; Pitocco, D; Crino, A; Spera, S; Tubili, C; Costanza, F; Maurizi, A; Cipolloni, L; Faldetta, Rc; Cappa, M; Pozzilli, P; Grp, I
GAD and IA-2 antibodies in relation to disease presentation and C-peptide secretion 1-gen-1996 Faldetta, Mc; Visalli, N; Cavallo, Mg; Andreani, D; Leslie, Rdg; Hava, M; Pozzilli, P
The GETREM study: New preliminary findings for the clinical remission in IDDM using logistic regression 1-gen-1997 Rowne, Pd; Lampeter, E; Deleeuw, I; Iafusco, D; Ionescutirgoviste, C; Kolouskova, S; Linn, T; Ludvigsson, J; Madascy, L; Mrozikiewicz, A; Podar, T; Prisco, M; Vavrinec, J; Vialettes, B; Visalli, N; Yilmaz, T; Pozzilli, P
Glucose RapidSpray (TM) for a new management of hypoglycaemia in children up to 5 years of age with type 1 diabetes 1-gen-2008 Pronina, E; Petraikina, H; Antsiferov, M; Duchareva, O; Guglielmi, C; Khazrai, M; Pozzilli, P
High and standard dose of nicotinamide in recent onset insulin dependent diabetes (the IMDIAB 6 Study) 1-gen-1998 Visalli, N; Ghirlanda, G; Pozzilli, P; Grp, Is.
HLA and insulin genes: Bayesian networks confirm interaction between the two most important susceptibility genes in type 1 diabetes in a French caucasian population 1-gen-2010 Portuesi, R; Bohm, Bo; Julier, C; Pozzilli, P
HLA-dependent autoantibodies against post-translationally modified collagen type II in type 1 diabetes mellitus 1-gen-2013 Strollo, R; Rizzo, P; Spoletini, M; Landy, R; Hughes, C; Ponchel, F; Napoli, N; Palermo, A; Buzzetti, R; Pozzilli, P; Nissim, A
HLA-MATCHED CONTROL SUBJECTS ARE ESSENTIAL IN STUDIES OF SUSCEPTIBILITY TO IDDM - REPLY 1-gen-1995 Pozzilli, P; Buzzetti, R; Bottazzo, G; Tosi, R
HUMAN INSULINOMA CELL-LINE EXPRESSING CONSTITUTIVE BETA-CELL GENES 1-gen-1995 Baroni, Mg; Gragnoli, C; Cavallo, Mg; Latini, L; Valente, L; Andreani, D; Pozzilli, P
Hyperexpression of GAD in the islets may be relevant but is it sufficient to induce autoimmune insulitis? 1-gen-1997 Pozzilli, P; Leslie, Rdg
HYPOMAGNESEMIA IN IDDM PATIENTS WITH MICROALBUMINURIA AND CLINICAL PROTEINURIA - REPLY 1-gen-1994 Pozzilli, P
Identification of type 1 diabetic patients with insulitis at diagnosis by Tc-99m-IL2 scintigraphy 1-gen-1998 Signore, A; Chianelli, M; Visalli, N; Barone, R; Annovazzi, A; Di Leve, G; Parisella, Mg; Pozzilli, P; Grp, Is
Ii-key/MHC class II epitope hybrid technology and ELISPOT as say in type 1 diabetes 1-gen-2006 Vadacca, M; Valorani, G; Humphreys, Re; Kallinteris, N; Valente, L; Pozzilli, P; Group, I
Ii-key/MHC class II epitope hybrid technology to detect T cell response to insulin and GAD in type 1 diabetes. 1-gen-2007 Vadacca, M; Valorani, G; Humphreys, R; Kallinteris, N; Valente, L; D'Agostino, G; Pozzilli, P; Grp, I.
IMMUNOTHERAPY IN PRE-TYPE-1 DIABETES-MELLITUS 1-gen-1990 Bach, Jf; Dupre, J; Eisenbarth, Gs; Harrison, Lc; Maclaren, Nk; Nerup, J; Pozzilli, P
IN-VIVO DETECTION OF ACTIVATED LYMPHOCYTES IN THE ENDOCRINE PANCREAS - A NEW TOOL FOR IDDM PREDICTION 1-gen-1995 Signore, A; Chianelli, M; Picarelli, A; Ferretti, E; Greco, M; Multari, M; Demattia, G; Pozzilli, P
Mostrati risultati da 47 a 66 di 128
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile